Zota Health Care's Q1 FY 2025-26 Quarterly Results

Result Summary

• Zota Health Care Ltd reported a 108.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 85.5%.
• Its expenses for the quarter were up by 97.2% QoQ and 71.7% YoY.
• The net profit increased 99.1% QoQ and increased 8.3% YoY.
• The earnings per share (EPS) of Zota Health Care Ltd declined at 4.6 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Zota Health Care Ltd is a company that operates within the pharmaceutical industry. The company is primarily engaged in the manufacturing and distribution of pharmaceutical products. Its portfolio includes a range of formulations in various therapeutic areas, catering to both domestic and international markets. Zota Health Care Ltd has positioned itself as a player in the healthcare sector, providing generic medications and focusing on research and development to expand its product offerings. Recent developments within the company or industry, if any, are not available in the provided data.

Revenue

In the first quarter of the fiscal year 2026 (Q1FY26), Zota Health Care Ltd reported a total income of ₹104.46 crores. This represents a substantial increase of 108.5% from the previous quarter (Q4FY25), where the total income was ₹50.09 crores. Compared to the same quarter last year (Q1FY25), where the total income was ₹56.32 crores, there is an 85.5% year-over-year growth. This indicates a significant rise in revenue over both the quarter and the year. The sharp increase in income suggests that the company might have experienced a boost in sales or other income streams during this period, leading to a considerable enhancement in its financial performance for the quarter.

Profitability

For Q1FY26, Zota Health Care Ltd reported a loss before tax of ₹13.08 crores, which is greater than the loss of ₹9.51 crores recorded in Q4FY25, representing a 37.5% quarter-over-quarter increase in the loss. Compared to Q1FY25, where the loss before tax was ₹12.16 crores, there is a 7.6% increase year-over-year. The profit after tax for Q1FY26 was a loss of ₹13.78 crores, which increased from a loss of ₹6.92 crores in the previous quarter, marking a 99.1% increase in the loss. Compared to a loss of ₹12.72 crores in Q1FY25, the loss grew by 8.3% year-over-year. The earnings per share (EPS) for the quarter stood at -₹4.60, showing a decline from -₹2.60 in Q4FY25, but a slight improvement from -₹4.80 in Q1FY25. These metrics reflect ongoing challenges in reaching profitability, with losses continuing to impact the company's financial health over both the quarter and the year.

Operating Metrics

The total expenses for Zota Health Care Ltd in Q1FY26 amounted to ₹117.55 crores, which is a 97.2% increase from the previous quarter (Q4FY25) where expenses were ₹59.60 crores. On a year-over-year basis, expenses increased by 71.7% from ₹68.48 crores in Q1FY25. The tax expense for Q1FY26 was ₹0.69 crores, contrasting with a tax benefit of -₹2.59 crores in Q4FY25, representing a significant change. Compared to Q1FY25, where the tax was ₹0.56 crores, there is a 23.2% increase. These figures highlight notable changes in the company's expense management and tax obligations, which have impacted the overall operating performance for the quarter.